NYSE ARCA | ETF
The fund will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents as well as in securities not included in the index, but which BFA believes will help the fund track the index.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 4.89% |
| PRAX | Praxis Precision Medicines Inc | Healthcare | Biotechnology | 4.75% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 4.40% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 4.29% |
| CERE | Cerevel Therapeutics Holdings Inc | Healthcare | Biotechnology | 4.05% |
| XENE | Xenon Pharmaceuticals Inc | Healthcare | Biotechnology | 3.98% |
| PTCT | PTC Therapeutics Inc | Healthcare | Biotechnology | 3.93% |
| SRRK | Scholar Rock Holding Corp | Healthcare | Biotechnology | 3.91% |
| ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 3.89% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.88% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.79% |
| 326030 | Sk Biopharmaceuticals Co Ltd | Healthcare | Biotechnology | 3.76% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 3.73% |
| AXNX | Axonics Modulation Technologies Inc | Healthcare | Medical Devices | 3.69% |
| LBPH | Longboard Pharmaceuticals Inc | Healthcare | Biotechnology | 3.66% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.65% |
| CNTA | Centessa Pharmaceuticals PLC ADR | Healthcare | Biotechnology | 3.49% |
| DNLI | Denali Therapeutics Inc | Healthcare | Biotechnology | 3.47% |
| CPRX | Catalyst Pharmaceuticals Inc | Healthcare | Biotechnology | 3.46% |
| SUPN | Supernus Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.41% |